Health-care composition for regulating intestinal flora, and application thereof

A technology for regulating intestinal flora and composition, applied in the direction of application, lactobacillus, bifidobacteria, etc., can solve the problems of limited intestinal flora regulation and single probiotics, and achieve good regulation and therapeutic effect

Inactive Publication Date: 2018-06-29
GUANGZHOU RAINHOME PHARM&TECH CO LTD
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Chinese invention patent 200510033150.3 discloses a yogurt powder containing chitosan, which is mainly composed of the following components by weight: 1-5 parts of chitosan, 50-80 parts of milk powder, 0.5-5 parts of acidulant, fruit powder 5-15 parts, 1-5 parts of active lactic acid bacteria freeze-dried powder, also contains sweeteners that can adjust taste, fruc

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Health-care composition for regulating intestinal flora, and application thereof
  • Health-care composition for regulating intestinal flora, and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A health care composition for regulating intestinal flora, which is prepared from the following components: 10-20 parts of chitosan, 20 parts of xylo-oligosaccharide, 14 parts of galacto-oligosaccharide, 3 parts of inulin, polyfructosaccharide 5 parts, 3 parts of sodium hyaluronate, 40 parts of compound probiotic powder.

[0030] The compound probiotic powder described therein consists of the following components by weight: 19 parts of Lactobacillus acidophilus, 3 parts of Lactobacillus casei subspecies cheese, 15 parts of Bifidobacterium longum, 20 parts of Bifidobacterium bifidum, 20 parts of Mycobacterium, 15 parts of Streptococcus thermophilus, 3 parts of Lactobacillus reuteri.

Embodiment 2

[0032] A health care composition for regulating intestinal flora, which is prepared from the following components: 10-20 parts of chitosan, 40 parts of xylooligosaccharide, 20 parts of galactooligosaccharide, 15 parts of inulin, polyfructosaccharide 20 parts, 10 parts of sodium hyaluronate, 60 parts of compound probiotic powder.

[0033] The compound probiotic powder described therein consists of the following components by weight: 40 parts of Lactobacillus acidophilus, 20 parts of Lactobacillus casei subspecies cheese, 30 parts of Bifidobacterium longum, 35 parts of Bifidobacterium bifidum, 40 parts of Mycobacterium, 25 parts of Streptococcus thermophilus, 20 parts of Lactobacillus reuteri.

Embodiment 3

[0035] A health care composition for regulating intestinal flora, which is prepared from the following components: 15 parts of chitosan, 30 parts of xylooligosaccharide, 17 parts of galactooligosaccharide, 9 parts of inulin, and 12.5 parts of polyfructosaccharide , 6.5 parts of sodium hyaluronate, 50 parts of compound probiotic powder.

[0036] The compound probiotic powder described therein consists of the following components by weight: 30 parts of Lactobacillus acidophilus, 12 parts of Lactobacillus casei subspecies cheese, 23 parts of Bifidobacterium longum, 28 parts of Bifidobacterium bifidum, 30 parts of Mycobacterium, 20 parts of Streptococcus thermophilus, 12 parts of Lactobacillus reuteri.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a health-care composition for regulating the intestinal flora, and application thereof, which belong to the field of health-care products. The health-care composition for regulating the intestinal flora is prepared from the following ingredients: 10 to 20 parts of chitosan, 20 to 40 parts of xylooligosaccharide, 14 to 20 parts of galactooligosaccharide, 3 to 15 parts of inulin, 5 to 20 parts of polyfructose, 3 to 10 parts of sodium hyaluronate, and 40 to 60 parts of compound probiotic powder. Tests indicate that thehealth-care composition for regulating the intestinalflora has a remarkable effect on regulating the intestinal flora and is suitable for being prepared into related products forpopularizationand application.

Description

technical field [0001] The invention relates to a health care composition for regulating intestinal flora and an application thereof, belonging to the field of health care products. Background technique [0002] Intestinal flora, normal microorganisms in the human intestinal tract, such as bifidobacteria, lactobacilli, etc., can synthesize a variety of vitamins necessary for human growth and development, such as B vitamins (vitamins B1, B2, B6, B12), vitamin K, tobacco It can also use protein residues to synthesize essential amino acids, such as aspartic acid, phenylalanine, valine, and threonine, and participate in the metabolism of carbohydrates and proteins. At the same time, it can also promote iron, Absorption of mineral elements such as magnesium and zinc. These nutrients play an important role in human health, and once they are deficient, they can cause various diseases. The 10 trillion bacteria that live in the human gut can affect body weight and digestion, protec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L33/135A23L33/125A23L33/22A23L33/10
CPCA23L33/10A23L33/125A23L33/135A23L33/22A23V2002/00A23V2400/125A23V2400/113A23V2400/173A23V2400/249A23V2400/517A23V2400/531A23V2400/533A23V2200/3202A23V2200/3204A23V2250/511A23V2250/5062A23V2250/5116A23V2250/28
Inventor 李龙车七石
Owner GUANGZHOU RAINHOME PHARM&TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap